Drug and Alcohol Dependence
Volume 67, Issue 1 , Pages 13-26 , 1 June 2002

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

  • Marsha M Linehan

      Affiliations

    • Behavioral Research and Therapy Clinics, Department of Psychology, University of Washington, Box 351525, Seattle, WA 98195-1525, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-206-543-9886; fax: +1-206-616-1513
    • ,
  • Linda A Dimeff

      Affiliations

    • The Behavioral Technology Transfer Group, 4556, University Way, College Center Building, Suite 222, Seattle, WA 98105, USA
    • Tel.: +1-206-675-8588; fax: +1-206-675-8590.
    • ,
  • Sarah K Reynolds

      Affiliations

    • Behavioral Research and Therapy Clinics, Department of Psychology, University of Washington, Box 351525, Seattle, WA 98195-1525, USA
    • ,
  • Katherine Anne Comtois

      Affiliations

    • Behavioral Research and Therapy Clinics, Department of Psychology, University of Washington, Box 351525, Seattle, WA 98195-1525, USA
    • ,
  • Stacy Shaw Welch

      Affiliations

    • Behavioral Research and Therapy Clinics, Department of Psychology, University of Washington, Box 351525, Seattle, WA 98195-1525, USA
    • ,
  • Patrick Heagerty

      Affiliations

    • Department of Biostatistics, University of Washington, Seattle, WA 98195-7232, USA
    • Tel.: +1-206-616-2720; fax: +1-206-616-2724.
    • ,
  • Daniel R Kivlahan

      Affiliations

    • Center of Excellence in Substance Abuse Treatment and Education, VA Puget Sound Health Care System, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98108-8280, USA
    • Tel.: +1-206-764-2457; fax: +1-206-764-2293.

Received 9 July 2001 ,Revised 30 December 2001 ,Accepted 10 January 2002.

References 

  1. Beautrais AL, Joyce PR, Mulder RT. Cannabis abuse and serious suicide attempts. Addiction. 1999;94:1155–1164
  2. Borkovec TD. Control groups and comparison groups in psychotherapy outcome research. NIDA Research Monograph. 1990;104:50–65
  3. Borkovec TD. Between-group therapy outcome research: design and methodology. NIDA Research Monograph. 1993;137:249–289
  4. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry. 1997;54:71–80
  5. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence. 2001;61:271–280
  6. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects. Archives of General Psychiatry. 1994;51:989–997
  7. DeJong CA, Van den Brink W, Harteveld FM, Van der Wielen EG. Personality disorders in alcoholics and drug addicts. Comprehensive Psychiatry. 1993;34:87–94
  8. Derogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychological Medicine. 1983;13:595–605
  9. Diggle PJ, Liang K, Zeger SL. Analysis of Longitudinal Data. New York: Oxford University Press; 1996;
  10. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. American Journal of Psychiatry. 1990;147:1002–1007
  11. Farrell M, Neeleman J, Griffiths P, Strang J. Suicide and overdose among opiate addicts. Addiction. 1996;91(3):321–323
  12. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders—Patient Edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995;
  13. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders—Patient Edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995;
  14. First MB, Spitzer RL, Gibbons M, Williams JBW, Benjamin L. User's guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996;
  15. Frances AJ, Fyer MR, Clarkin JF. Personality and suicide. Annals of the New York Academy of Sciences. 1986;487:281–293
  16. Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug and Alcohol Dependence. 2001;62:255–264
  17. Hien DA, Nunes E, Levin FR, Fraser D. Posttraumatic stress disorder and short-term outcome in early methadone treatment. Journal of Substance Abuse and Treatment. 2000;19:31–37
  18. Keller MB, Lavori PW, Friedman B, Nielsen EC, Endicott J, McDonald-Scott P, et al. The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry. 1987;44:540–548
  19. Kelly T, Soloff PH, Cornelius J, George A, Lis JA, Ulrich R. Can we study (treat) borderline patients? Attrition from research and open treatment. Journal of Personality Disorders. 1992;6:417–433
  20. Kidorf M, Stitzer ML, Brooner RK, Goldberg J. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug and Alcohol Dependence. 1994;36:221–226
  21. Kidorf M, King VL, Brooner RK. Integrating psychosocial services with methadone treatment: behaviorally contingent pharmacotherapy. In:  Strain EC,  Stitzer ML editor. Treatment of Opioid Dependence: Methadone and Alternative Medications. Baltimore, MD: Hopkins Press; 1998;
  22. Koerner K, Linehan MM. Research on dialectical behavior therapy for patients with borderline personality disorder. The Psychiatric Clinics of North America. 2000;23:151–167
  23. Kosten RA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity. Journal of Substance Abuse Treatment. 1989;6:163–168
  24. Linehan, M.M. 1977. Validation and psychotherapy. In: Bohart, A., Greenberg, L. (Eds.). Empathy reconsidered: New directions in psychotherapy. American Psychological Association, Washington, D.C.
  25. Linehan, M.M., Wagner, A.W., Cox, G., 1989. Parasuicide History Interview: (PHI). Comprehensive Assessment of Parasuicidal Behavior, University of Washington, Seattle, WA.
  26. Linehan MM, Heard HL, Brown M, Wagner AW. Parasuicide History Interview (PHI). Seattle, WA: University of Washington; 1990;
  27. Linehan MM, Armstrong HE, Suarez A, Allmon D, Heard HL. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry. 1991;48:1060–1064
  28. Linehan MM. Cognitive Behavioral Therapy of Borderline Personality Disorder. New York: Guilford Press; 1993;
  29. Linehan MM. Skills Training Manual for Treating Borderline Personality Disorder. New York: Guilford Press; 1993;
  30. Linehan MM, Heard HL. Social History Interview (SHI). Seattle, WA: University of Washington; 1994;
  31. Linehan MM, Tutek DA, Dimeff LA. Comprehensive Validation Therapy for Substance Abusers. Seattle, WA: University of Washington; 1996;
  32. Linehan, M.M., Dimeff, L.A., 1997. Dialectical Behavior Therapy for Substance Abuse Treatment Manual, University of Washington, Seattle, WA.
  33. Linehan MM, Schmidt H, Dimeff LA, Craft JC, Kanter J, Comtois KA. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. The American Journal of Addiction. 1999;8:279–292
  34. Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry. 1996;53:401–407
  35. Links PS, Heslegrave RJ, Mitton JE, van Reekum R, Patrick J. Borderline personality disorder and substance abuse: consequences of comorbidity. Canadian Journal of Psychiatry. 1995;40:9–14
  36. Loranger AW. Personality Disorder Examination (PDE). New York: DV Communications; 1988;
  37. Magura S, Rosenblum A, Lovejoy M, Handelsman L, Foote J, Stimmel J. Neurobehavioral treatment for cocaine—using methadone patients: a preliminary report. Journal of Addictive Diseases. 1994;13:143–160
  38. Marlatt GA. Harm Reduction: Pragmatic Strategies for Managing High Risk Behavior. New York: Guilford Press; 1998;
  39. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press; 1985;
  40. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychological services in substance abuse treatment. Journal of the American Medical Association. 1993;369:1953–1959
  41. Miller FT, Abrams T, Dulit RA, Fyer MR. Substance abuse in borderline personality disorder. American Journal of Drug and Alcohol Abuse. 1993;19:491–497
  42. Morral AR, McCaffrey D, Iguchi MY. Hardcore drug users claim to be occasional users: drug use frequency underreporting. Drug and Alcohol Dependence. 2000;57:193–202
  43. NIH Consensus Conference . Effective medical treatment of opiate addiction. American Medical Association. 1998;280:1936–1943
  44. Rawson RA, Hasson AL, Huber AM, McCann MJ, Ling W. A 3-year progress report on the implementation of LAAM in the United States. Society for the Study of Addiction to Alcohol and Other Drugs. 1998;93:533–540
  45. Rossow I, Lauritzen G. Balancing on the edge of death: suicide attempts and life-threatening overdoses among drug addicts. Addiction. 1999;94:209–219
  46. Rounsaville BJ, Glazer W, Wilber CH, Weissmann MM, Kleber HD. Short-term interpersonal psychotherapy in methadone-maintained opiate addictions. Archives of General Psychiatry. 1983;40:629–636
  47. Rutherford MJ, Cacciola JS, Alterman AI. Relationships of personality disorders with problem severity in methadone patients. Drug and Alcohol Dependence. 1994;35:69–76
  48. Savage C, Karp EG, Curran SF, Hanlon TE, McCabe OL. Methadone/LAAM maintenance: a comparison study. Comprehensive Psychiatry. 1976;17:415–424
  49. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry. 1997;54:713–720
  50. Skodol AE, Oldham JM, Gallaher PE. Axis II comorbidity of substance use disorders among patients referred for treatment of personality disorders. American Journal of Psychiatry. 1999;156:733–738
  51. Sobell MB, Sobell LC, Klajner F, Pavan D, Basian E. The reliability of a timeline method for assessing normal drinker college students' recent drinking history: utility for alcohol research. Addictive Behaviors. 1986;11:149–161
  52. Soloff PH. Is there any drug treatment of choice for the borderline patient?. Acta Psychiatrica Scandinavica. 1994;379:50–55
  53. Stone MH, Hurt SW, Stone DK. The PI 500: Long-term follow-up of borderline inpatients meeting DSM-III criteria. I: Global outcome. Journal of Personality Disorders. 1987;1:291–298
  54. Swann WBJ. Quest for accuracy in person perception: a matter of pragmatics. Psychological Review. 1984;91:457–477
  55. Swann WB, Stein-Seroussi A, Giesler RB. Why people self-verify. Journal of Personality and Social Psychology. 1992;62:392–401
  56. Trull TJ, Sher KJ, Minds-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clinical Psychology Review. 2000;20:235–253
  57. Visher, C., McFadden, K., 1991. A Comparison of Urinalysis Technologies for Drug Testing in Criminal Justice, Research in Action. National Institute of Justice, pp. 1–5.
  58. Waldinger RJ, Frank AF. Clinicians' experiences in combining medication and psychotherapy in the treatment of borderline patients. Hospital and Community Psychiatry. 1989;40:712–718
  59. Wampold BE, Serlin RC. The consequences of ignoring a nested factor on measures of effect size in analysis of variance. Psychological Methods. 2000;5:425–433
  60. White SJ, Freedman LS. Allocation of patients to treatment groups in a controlled clinical study. British Journal of Cancer. 1978;37:849–857
  61. Woody GE, Luborsky L, McLellan AT, O'Brien CP, Beck AT, Blaine J, et al. Psychotherapy for opiate addicts. Does it help?. Archives of General Psychiatry. 1983;40(6):639–645
  62. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Sociopathy and psychotherapy outcome. Archives of General Psychiatry. 1985;42:1081–1086
  63. Woody, G.E., McLellan, A.T., Luborsky, L. O'Brien, C.P., 1995. Psychotherapy in community methadone programs: a validation study. American Journal of Psychiatry 152, 1302–1308.

PII: S0376-8716(02)00011-X

Drug and Alcohol Dependence
Volume 67, Issue 1 , Pages 13-26 , 1 June 2002

Article Tools

* Image Usage & Resolution